Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Piper Sandler Downgrades Horizon Therapeutics (HZNP) to Neutral Pending Takeover
December 12, 2022 12:09 PM ESTPiper Sandler analyst David Amsellem downgraded Horizon Therapeutics (NASDAQ: HZNP) from Overweight to Neutral with a price target of $116.50 (from $110.00) after the company agreed to be acquired by Amgen.
For an analyst ratings summary and ratings history on Horizon Therapeutics... More
Amgen (AMGN) confirms it will acquire Horizon Therapeutics (HZNP) for $116.50 per share
December 12, 2022 6:29 AM ESTAmgen (NASDAQ: AMGN) confirms it will acquire Horizon Therapeutics (NASDAQ: HZNP) for $116.50 per share.
